1. Home
  2. VSME vs DCOY Comparison

VSME vs DCOY Comparison

Compare VSME & DCOY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VS Media Holdings Limited

VSME

VS Media Holdings Limited

HOLD

Current Price

$0.75

Market Cap

3.3M

Sector

N/A

ML Signal

HOLD

DCOY

Decoy Therapeutics Inc. Common Stock

N/A

Current Price

$5.85

Market Cap

3.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VSME
DCOY
Founded
2013
N/A
Country
Hong Kong
United States
Employees
N/A
2
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3M
3.4M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
VSME
DCOY
Price
$0.75
$5.85
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$30.00
AVG Volume (30 Days)
47.0K
18.5K
Earning Date
04-14-2026
05-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.07
$0.53
52 Week High
$3.21
$9.09

Technical Indicators

Market Signals
Indicator
VSME
DCOY
Relative Strength Index (RSI) 29.83 50.80
Support Level $0.09 $0.61
Resistance Level $1.19 $7.50
Average True Range (ATR) 0.07 0.64
MACD -0.02 -0.42
Stochastic Oscillator 23.46 8.99

Price Performance

Historical Comparison
VSME
DCOY

About VSME VS Media Holdings Limited

VS Media Holdings Ltd manages a network of digital Creators who create and publish content to social media platforms such as YouTube, Facebook, Instagram, and TikTok. Its Creators include influencers, KOLs-Key Opinion Leaders, bloggers, and other content creators who cultivate fan bases on social media platforms. The company's business provides value to two business stakeholders: Creators and Brands. The Value to Creators, that empowers and supports Creators by providing them with production facilities, training, and funding to produce quality content and the Value to Brands, where the company bridges the divide between Brands and Creators by helping Brands reach their target audience effectively by advising on content and budget and recommending specific Creators.

About DCOY Decoy Therapeutics Inc. Common Stock

Decoy Therapeutics Inc is a preclinical-stage biotechnology company developing peptide conjugate drug candidates using machine learning, artificial intelligence tools, and high-throughput synthesis techniques. The company's initial pipeline is focused on respiratory viruses and GI cancers.

Share on Social Networks: